This cohort study analyzed the safety and efficacy of immune checkpoint inhibitors in patients with cancer and autoimmune disease, and examined whether immune-related toxic effects were associated with outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264212 | PMC |
| http://dx.doi.org/10.1001/jamaoncol.2022.2081 | DOI Listing |
Publication Analysis
Top Keywords
toxic effects
8
patients cancer
8
cancer autoimmune
8
autoimmune disease
8
association toxic
4
effects survival
4
survival patients
4
disease treated
4
treated checkpoint
4
checkpoint inhibitor
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!